MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3233/jad-230811

Медицинская библиотека · Journal of Alzheimer's disease : JAD · 2024

Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.

Wu Liu-Yun, Chong Joyce R, Chong Jenny P C, Hilal Saima, Venketasubramanian Narayanaswamy, Tan Boon Yeow, Richards Arthur Mark, Chen Christopher P, Lai Mitchell K P

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Concomitant cerebrovascular diseases (CeVD) have been identified as an important determinant of Alzheimer's disease (AD) progression. Development of robust blood-based biomarkers will provide critical tools to evaluate prognosis and potential interventional strategies for AD with CeVD.

OBJECTIVE

This study investigated circulating placental growth factor (PlGF), a potent pro-angiogenic factor related to endothelial dysfunction and vascular inflammation, in an Asian memory clinic cohort of non-demented individuals as well as AD, including its associations with neuroimaging markers of CeVD.

METHODS

109 patients with AD, 76 cognitively impaired with no dementia (CIND), and 56 non-cognitively impaired (NCI) were included in this cross-sectional study. All subjects underwent 3T brain magnetic resonance imaging to assess white matter hyperintensities (WMH), lacunes, cortical infarcts, and cerebral microbleeds (CMBs). Serum PlGF concentrations were measured by electrochemiluminescence immunoassays.

RESULTS

Serum PlGF was elevated in AD, but not CIND, compared to the NCI controls. Adjusted concentrations of PlGF were associated with AD only in the presence of significant CeVD. Elevated PlGF was significantly associated with higher burden of WMH and with CMBs in AD patients.

CONCLUSIONS

Serum PlGF has potential utility as a biomarker for the presence of CeVD, specifically WMH and CMBs, in AD. Further studies are needed to elucidate the underlying pathophysiological mechanisms linking PlGF to CeVD, as well as to further assess PlGF's clinical utility.

Для цитирования: Wu Liu-Yun, Chong Joyce R, Chong Jenny P C, Hilal Saima, Venketasubramanian Narayanaswamy, Tan Boon Yeow, Richards Arthur Mark, Chen Christopher P, Lai Mitchell K P. Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer's Disease.. Journal of Alzheimer's disease : JAD. 2024. DOI: 10.3233/jad-230811.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.